FAQ

APACMed was legally established in November 2014, and officially launched on 25th April 2015.

“Asia Pacific” means the territories and/or economies in the Asia Pacific region, namely: Australia, Bangladesh, Bhutan, Brunei, Cambodia, China, Hong Kong, India, Indonesia, Japan, Laos, Macau, Malaysia, Mongolia, Myanmar, Nepal, New Zealand, North Korea, Pacific Islands, Pakistan, Papua New Guinea, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Timor Leste, Vietnam.

Medical technology is a broad term covering medical devices, equipment and in vitro diagnostics. Examples of medical technologies are wide ranging and very diverse: from contact lenses to rubber gloves, syringes and needles. From pacemakers, CT’s and MRI’s, surgical robots and laboratory analyzers to artificial hip and knee implants. And from insulin pumps and dialysis machines to pregnancy tests, catheters and wheelchairs.

The World Health Organisation (WHO) defines a medical device as:

1. “Any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination, for human beings, for one or more of the specific medical purpose(s) of:

1. diagnosis, prevention, monitoring, treatment or alleviation of disease
2. diagnosis, monitoring, treatment, alleviation of or compensation for an injury
3. investigation, replacement, modification, or support of the anatomy or of a physiological process,
4. supporting or sustaining life
5. control of conception
6. disinfection of medical devices
7. providing information by means of in vitro examination of specimens derived from the human body and does not achieve its primary intended action by pharmacological, immunological or metabolic means, in or on the human body, but which may be assisted in its intended function by such means”.

APACMed membership is open to any company or organisation with an interest in the medical technology industry in Asia Pacific. This includes manufacturers and developers of innovative medical devices, equipment or IVD, digital health solution providers, national industry associations, service providers (e.g. consultants, CROs, recruiters), distributors, contract manufacturers and investors. To be eligible for membership a legal entity in Asia Pacific is required.

The membership application process is very straightforward. The first step is to contact our Business Development Director, who will provide you with more information about APACMed, our membership application form and details of our membership fees. Annual fees are pro-rated based on the number of remaining months in the calendar year.

Companies with sales of less than USD 50 million may submit a membership application for our SME category. Membership fees for SME’s are substantially lower than those payable by our large, multinational Corporate Members.

Institutional investors, such as venture capital or private equity firms, may join APACMed as Associate Members. However, the portfolio companies of such investors may prefer to join directly under the SME membership category.

Members of APACMed share a common vision: improving the standards of care, driving access and collaboration, and shaping the future of healthcare in Asia Pacific. Members benefit from market insights and industry intelligence, exclusive free webinars, special rates on registration for APACMed events and access to our Functional Committees. Membership of the Association also provides unparalleled networking with industry peers at exclusive events.

Find out more about APACMed Membership Benefits here.

APACMed promotes ethical interactions between the medical technology industry and health care professionals to advance its mission. The APACMed Code of Ethical Conduct was introduced in December 2015 and made effective 1 January 2016. It is a requirement for our Corporate Members to subscribe to this Code.

The purpose of this Code is to facilitate ethical interactions between its Corporate Members that develop, manufacture, sell, market, or distribute medical technologies in Asia Pacific and those individuals and entities that use, recommend, purchase, or prescribe medical technologies in Asia Pacific.

Following on from the Board’s decision in September 2016 to eliminate direct sponsorship of HCPs to third party conferences by 1 January 2018, the APACMed Code of Ethics has been amended.

We are unable to provide any advice on the use of specific products or services provided by our member organisations. We kindly request that you approach the company directly.